CMEXPRESS :: Millennium Medical Publishing

Welcome to CMExpress

Clinical Advances provides unique opportunities to earn valuable CME credits through a trusted partner.

Latest CMExpress Opportunities by Publication

Presentations Review: Recent Advances in the Treatment of T-cell Lymphomas: Owen A. O’Connor, MD, PhD; Volume 8, Issue 2 , Supplement 4

Clinical Monograph: Clinical Considerations for Older Patients With Glioblastoma: Lauren E. Abrey, MD, Fabio M. Iwamoto, MD, and Thomas Finnegan, PhD; Volume 8, Issue 1 , Supplement 1

Clinical Roundtable Monograph: Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Post-MASCC 2009 Discussion: Gary R. Morrow, PhD, MS, Susan G. Urba, MD, and Lee S. Schwartzberg, MD; Volume 7, Issue 12 , Supplement 22

Clinical Roundtable Monograph: Clinical and Pathological Diagnosis of Peripheral T-cell Lymphoma and Emerging Treatment Options: A Case-based Discussion: Jonathan Said, MD, and Lauren Pinter-Brown, MD; Volume 7, Issue 11 , Supplement 19

Presentations Review: Advances in the Treatment of T-cell Lymphomas: Francine Foss, MD; Volume 7, Issue 10 , Supplement 18

Clinical Roundtable Monograph: Current Management of Thromboembolism in Cancer Patients: Building a Consensus: Craig M. Kessler, MD, Gary H. Lyman, MD, MPH, FRCP (Edin), and Ajay K. Kakkar, MD; Volume 7, Issue 10 , Supplement 17

Presentations Review: A Summer of Hematologic Science: Bruce D. Cheson, MD, and Elizabeth Ashforth, PhD; Volume 7, Issue 9 , Supplement 15

Clinical Roundtable Mongraph: Evolving Strategies in the Treatment of MDS and AML: Richard Stone, MD, Mikkael Sekeres, MD, MS, and Guillermo Garcia-Manero, MD; Volume 7, Issue 8 , Supplement 14

Clinical Roundtable Monograph: Emerging Treatment Options in Adult Acute Myelogenous Leukemia: Elihu H. Estey, MD, Wendy Stock, MD, and Jerald P. Radich, MD; Volume 7, Issue 6 , Supplement 12

Clinical Monograph: New Opportunities for the Management of Cancer-Related Bone Complications: Allan Lipton, MD, Gordon A. Brown, DO, Gregory R. Mundy, MD, G. David Roodman, MD, PhD, and Matthew R. Smith, MD, PhD; Volume 7, Issue 5 , Supplement 11

Presentations Review: Recent Advances in the Treatment of Myelodysplastic Syndromes: David P. Steensma, MD; Volume 7, Issue 3 , Supplement 7

Clinical Monograph: Strategies for the Management of Iron Overload in the Transplant Setting: Richard J. O’Reilly, MD, Emanuele Angelucci, MD, Mark Walters, MD, Deborah Chirnomas, MD; Volume 6, Issue 5 , Supplement 11

Abstracts Review: Current Treatment Strategies for Myelodysplastic Syndromes: David P. Steensma, MD, Kenneth Miller, MD, German Pihan, MD, Elias Jabbour, MD, Mikkael A. Sekeres, MD, MS, Larry D. Cripe, MD; Volume 6, Issue 3 , Supplement 5

Clinical Roundtable Monograph: 5-ASA Dose-Response: Maximizing Efficacy and Adherence: Seymour Katz, MD, Gary R. Lichtenstein, MD, and Michael A. Safdi, MD; Volume 6, Issue 2 , Supplement 4

Abstract Summary: New Data on the Use of Biologic Agents for Crohn’s Disease and Ulcerative Colitis: Highlights from the 2009 CCFA Advances in IBD Meeting: Edward V. Loftus, MD; Volume 6, Issue 2 , Supplement 3

Abstract Summary: Biologic Therapies for Crohn’s Disease: Update from the 2009 ACG Meeting: David G. Binion, MD; Volume 6, Issue 1 , Supplement 2

Abstract Summary: New Research in Ulcerative Colitis: Optimizing 5-ASA Administration for Efficacy and Adherence: Charles A. Sninsky, MD; Volume 6, Issue 1 , Supplement 1

Clinical Roundtable Monograph: Treatment Challenges in the Management of Gastroparesis-Related GERD: Ronnie Fass, MD, Richard W. McCallum, MD, and Henry P. Parkman, MD; Volume 5, Issue 10 , Supplement 18

Presentation Review: Emerging Issues in Gastroenterology and Hepatology: Nathan M. Bass, MD, PhD, and Brian Feagan, MD; Volume 5, Issue 8 , Supplement 17

Roundtable Proceedings: Therapeutic Targets for Emerging Biologic Therapies in IBD: Stephen B. Hanauer, MD, Scott E. Plevy, MD, Bruce E. Sands, MD, MS, and Stephan R. Targan, MD; Volume 5, Issue 7 , Supplement 16

Clinical Roundtable Report: Emerging Issues in Ulcerative Colitis and Ulcerative Proctitis: Individualizing Treatment to Maximize Outcomes: Stephen B. Hanauer, MD, Daniel H. Present, MD, and David T. Rubin, MD; Volume 5, Issue 6 , Supplement 15

Clinical Roundtable Monograph: Utilizing Biologic Therapies in the Treatment of IBD: Maximizing Efficacy and Minimizing Risk in Moderate-to-Severe Ulcerative Colitis: Stephen B. Hanauer, MD, Gary R. Lichtenstein, MD, and Remo Panaccione, MD; Volume 5, Issue 5 , Supplement 14

Clinical Roundtable Monograph: Utilizing Biologic Therapies in the Treatment of IBD: Maximizing Efficacy and Minimizing Risk in Moderate-to-Severe Crohn’s Disease: Sunanda V. Kane, MD, MSPH, Gary R. Lichtenstein, MD, and David T. Rubin, MD; Volume 5, Issue 4 , Supplement 12

Clinical Roundtable Monograph: Evolving Strategies in Hepatocellular Carcinoma Screening and Treatment: A Discussion Post-AASLD 2008: Hashem B. El-Serag, MD, MPH, Robert G. Gish, MD, and Jorge A. Marrero, MD, MS; Volume 5, Issue 3 , Supplement 10

How It Works

To complete the post-test online:

Access the lesson by clicking Download PDF.
Click on the CME University link. You will need to register before you can access the electronic post-test.
(If you are not automatically directed to the post-test, go to the navigation menu, and search by Lesson ID #)
Upon successfully completing the post-test and evaluation, your certificate will be made available immediately.

If any of the lessons shown at right do not contain a CME University link, simply download and read that lesson, and follow the instructions on the post-test page for obtaining CME credit.